For patients comparing cash flow instead of just annual totals, that distinction matters as much as the headline monthly price
A lack of B12 interferes with your bodys ability to produce white blood cells
The response to linsitinib is inferior to the topoisomerase inhibitor topotecan, with median progression-free survival of 3.0 (95% CI 1.53.6) and 1.2 (95% CI 1.11.4) months for topotecan and linsitinib, respectively [159]
It may cause nausea, stomach cramps, decreased appetite, flushing, tiredness, yawning, darkened skin, spontaneous erections of the penis, and other side effects.There isn't enough information to know whether melanotan-II is safe for other uses
Cord blood glutathione depletion in preterm infants: correlation with maternal cysteine depletion